Navigating Regulatory Hurdles and Raw Material Volatility in the Atorvastatin API Market
Stability is the most sought-after commodity in the pharmaceutical world this year. In 2026, the Atorvastatin API Market is facing a complex landscape of regulatory tightening and fluctuating input costs. Approximately 50% of global manufacturers are currently reporting delays in "Drug Master File" (DMF) approvals as agencies like the FDA increase their focus on "Impurity Profiling" and...
0 Comments 0 Shares 80 Views 0 Reviews
Sponsored